陆静松

陆静松，浙江东阳人，朝晖特聘副研究员。2017年6月本科毕业于浙江工业大学（功能材料方向），2022年6月于浙江工业大学获得工学博士学位，师从车声雷教授和余靓教授；硕博连读期间在清华大学材料学院联合培养，指导老师为赵凌云教授。2022年10月于清华大学化学系从事博士后研究，合作导师为危岩教授和赵凌云教授。2025年11月入职浙江工业大学。主要从事光电磁功能材料的合成方法学研究、纳米药物递送体系与疾病（肿瘤）高效诊疗研究以及新型全细胞来源肿瘤疫苗的开发，主持国家自然科学基金青年基金1项，中国博士后科学基金面上项目1项。迄今共发表SCI论文30多篇，其中以第一作者/通讯作者在J Control Release, Chem Eng J, Nano Res, ACS Appl Mater Interfaces, J Mater Chem B等期刊上发表论文十余篇。

1、国家自然科学基金委员会，青年科学基金项目（C类），32501239，基于Criegee机制的新型肿瘤臭氧治疗及免疫效应研究，2026-01至2028-12，在研，主持

2、中国博士后科学基金会，第75批面上资助，2024M751654，油凝胶介导的肿瘤臭氧治疗及级联增效抗肿瘤机制研究，2024-07至2025-11，结题，主持

[1]Jingsong Lu, Zhenhu Guo, Wensheng Xie*, et al., Macro-to-Nano: Multi-Scale Functionalized Biomaterials for Cancer Magnetic Hyperthermia Therapy (MHT)[J]. Science China-Materials, 2025, DOI:10.1007/s40843-025-3690-y.

[2]Jingsonng Lu, Jing Yu, Shenglei Che, Yen Wei*, Lingyun Zhao*, et al., Investigation of the impact of local tumor phenolic-chemistry for dual starvation and vaccination therapy[J]. Chemical Engineering Journal, 2025, 524, 169504.

[3]Jingsong Lu, Jing Yu, Shenglei Che, Lingyun Zhao*, et al., Saponin-mediated cell membrane interference nanomedicine potentiates tumor chemo-immunotherapy[J]. Biomaterials Science, 2025, 13(14), 3942-3957.

[4]Jingsonng Lu*, Jing Yu, Shenglei Che, Yen Wei*, Lingyun Zhao*, et al., Intracellular Criegee's mechanism-based synergistic ozone therapy mediated by oleogels for cancer treatment[J]. Journal of Controlled Release, 2024, 370, 879-890.

[5]Jingsonng Lu#*, Yupei Wang#, Jing Yu, Shenglei Che, Yen Wei*, Lingyun Zhao*, et al., Cancer nutritional-immunotherapy with NIR-II laser-controlled ATP release based on material repurposing strategy[J]. Journal of Materials Chemistry B, 2024, 12(19), 4629-4641.

[6]Jingsonng Lu*, Yen Wei*, Lingyun Zhao*, et al., DC-Derived Whole Cell Cytokines Nano-Regulator for Remodeling Extracellular Matrix and Synergizing Tumor Immunotherapy[J]. RSC Medicinal Chemistry, 2024, 15(12), 4090-4099.

[7]Jingsonng Lu, Shenglei Che*, Yen Wei*, Lingyun Zhao*, et al., Physical Dissolution Combined with Photodynamic Depletion: A Two-Pronged Nanoapproach for Deoxygenation-Driven and Hypoxia-Activated Prodrug Therapy[J]. ACS Applied Bio Materials, 2023, 6(9), 3902-3911.

[8]Jingsonng Lu, Yen Wei*, Lingyun Zhao*, et al., Acidity-Triggered Charge-Convertible Conjugated Polymer for Dihydroartemisinin Delivery and Tumor-Specific Chemo-Photothermal Therapy[J]. ACS Applied Bio Materials, 2023, 6(6), 2303-2313.

[9]Jingsong Lu, Zhenhu Guo, Lingyun Zhao*, et al., Local destruction of tumors for systemic immunoresponse: engineering antigen-capturing nanoparticles as stimulus-responsive immunoadjuvants[J]. ACS Applied Materials & Interfaces, 2022, 14(4), 4995-5008.

[10]Jingsong Lu, Jing Yu*, Lingyun Zhao*, et al., Hypoxia-Overcoming Breast-Conserving Treatment by Magnetothermodynamic Implant for a Localized Free-Radical Burst Combined with Hyperthermia[J]. ACS Applied Materials & Interfaces, 2021, 13(30), 35484-35493.

[11]Jingsong Lu, Yu-Fen Huang*, Lingyun Zhao*, et al., Gold-iron selenide nanocomposites for amplified tumor oxidative stress-augmented photo-radiotherapy[J]. Biomaterials Science, 2021, 9(11), 3979-3988.

[12]Jingsong Lu, Shenglei Che, Jing Yu*, Lingyun Zhao*, et al., Dihydroartemisinin loaded layered double hydroxide nanocomposites for tumor specific photothermal-chemodynamic therapy[J]. Journal of Materials Chemistry B, 2020, 8(48), 11082-11089.

[13]Ying Li, Jingsong Lu*, Lingyun Zhao*, et al., NanoAlum Based Delivery System to Formulate In-Situ Vaccine for Personalized Cancer Immunotherapy[J]. Nano Research, 2025, 18(9), 94907642.

[14]Peilun Hu, Jingsong Lu*, Lingyun Zhao*, et al., Injectable Magnetic Hydrogel Filler for Synergistic Bone Tumor Hyperthermia Chemotherapy[J], ACS Applied Bio Materials, 2024, 7(3), 1569-1578.